FRR Shares (Makes you Realise)

Equity

Home/ Are You A Trader/ Market Info/ Company Profile/ Smart Quotes

COMPANY PROFILE

SENORES PHARMACEUTICALS LTD.

NSE : SENORESBSE : 544319ISIN CODE : INE0RB801010Industry : Pharmaceuticals & DrugsHouse : Private

BSE1052.3597.55 (+10.22 %)

PREV CLOSE (Rs.) 954.80

OPEN PRICE (Rs.) 969.95

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 46816

TODAY'S LOW / HIGH (Rs.)942.05 1062.00

52 WK LOW / HIGH (Rs.)491 1062

NSE1050.3595.7 (+10.02 %)

PREV CLOSE( Rs. ) 954.65

OPEN PRICE (Rs.) 966.90

BID PRICE (QTY) 1050.35 (209)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 1325468

TODAY'S LOW / HIGH(Rs.) 941.00 1063.80

52 WK LOW / HIGH (Rs.)491 1063.8

More From Company Profile

Smart Quotes

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Trade Value (Rs. in Lacs)

470.00

Dividend Yield(%)

0.00

TTM EPS (Rs.)

4.40

P/E Ratio

239.33

Book Value (Rs.)

162.83

Face Value (Rs.)

MCap (Rs. in Mn)

48464.49

Price/Earning (TTM)

144.76

Price/Sales (TTM)

45.68

Price/Book (MRQ)

6.46

PAT Margin (%)

9.57

ROCE (%)

2.19

Incorporation Year : 26-12 2017

Management Info :

Sanjay Shaileshbhai Majmudar - Chairman Swapnil Jatinbhai Shah - Managing Director

Registered Office :

Address : 1101 To 1103, 11th Floor, South Tower,One 42 Opp. Jayantilal Park,Ambali Bopal Road,
Ahmedabad,
Gujarat-380054

Phone : 079-29999857

Email : info@senorespharma.com

Website : www.senorespharma.com

Registrars Details :

MUFG Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE

NEWS

15May Senores Pharmaceuticals informs about
Senores Pharmaceuticals has informed regarding copy of Newspaper Publica..

04Apr Senores Pharmaceuticals informs about
Pursuant to Regulation 30 of the Securities and Exchange Board of India..

09Mar Senores Pharmaceuticals informs about
Pursuant to Regulation 30(6) read with Schedule III of the Securities an..

Financials

	QTR Mar 26	ANNUAL 26
Net Profit	84.8	202.5
Gross Profit	126.9	274.6
Operating Profit	187.1	476.7
Net Sales	368.1	1060.9

Rs. in Millions

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)

27934.60 (1.52%)

M.Cap (Rs. in Cr)59359.08

Pfizer (BSE)

4939.05 (5.36%)

M.Cap (Rs. in Cr)22595.03

Astrazeneca Pharma I (BSE)

8488.45 (1.66%)

M.Cap (Rs. in Cr)21221.13

Hester Biosciences (BSE)

1834.05 (5.67%)

M.Cap (Rs. in Cr)1560.20

Shareholding Pattern

	PROMOTERS	45.82%
	NON-INSTITUTION	40.93%
	MUTUAL FUNDS/UTI	5.07%
	FI/BANKS/INSURANCE	2.97%
	GOVERNMENT	0%
	FII	0%

Mf Holding

Scheme Name

Hold(%)

Mahindra Manulife L...

1.07

Bank of India Multi...

0.84

ICICI Pru Pharma He...

0.65

Bank of India Mid &...

0.47

Motilal Oswal BSE H...

0.06

Bandhan BSE Healthc...

0.06

Attention Investors

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month, Issued in the interest of Investors.

Risk Disclosure on Derivatives | Smart ODR | Mandatory Display | KYC Validation Links

BSE / NSE SEBI Registration No. INZ000279232, Depository Participant SEBI Registration No. – IN DP CDSL 132-2015

Mutual funds - ARN No. 81648 , Investment Adviser SEBI Registration No. : INA000008668.

close X

Download Client Registration Documents

Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do's & Don't's) in Vernacular Language :

Assamese Bengali Gujarati Hindi Kanada

Kashmiri Konkani Malyalam Marathi Oriya

Punjabi Sindhi Tamil Telegu Urdu

NOTE : " This document is a translated version of the client registration documents in English and is being provided in vernacular language to facilitate better understanding by the investors. In case of any ambiguity, the contents of the English version would prevail. "

CLOSE X

Risk Disclosures On Derivatives

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22